Codexis, Inc.
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvā¦ read more
Healthcare
Biotechnology
16 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.40
Price-5.41%
-$0.08
1Y
Price
Market Cap
$127.191m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-189.0%
EBITDA Margin-228.0%
Net Profit Margin-91.7%
Free Cash Flow Margin-189.0%
EBITDA Margin-228.0%
Net Profit Margin-91.7%
Free Cash Flow MarginRevenue
$78.092m
-10.8%
1y CAGR-25.2%
3y CAGR-10.8%
5y CAGREarnings
-$31.990m
+2.0%
1y CAGR-36.8%
3y CAGR-42.1%
5y CAGREPS
-$0.37
+14.6%
1y CAGR-28.1%
3y CAGR-34.7%
5y CAGRBook Value
$43.234m
$129.370m
Assets$86.136m
Liabilities$72.903m
DebtDebt to Assets
56.4%
-1.2x
Debt to EBITDAFree Cash Flow
-$22.119m
-14.8%
1y CAGR-675.2%
3y CAGR-478.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company